View allAll Photos Tagged brainstorming

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

036

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

MEDICAL INGENUITY — AT HALF THE PRICE

Hosted by Abbott

One thing we are very good at: creating medical marvels. Not so good at: making them affordable. So how do you squeeze more value out of innovation? One answer is to bring affordability into the ideation and design process from the very beginning. A conversation that probes the least explored part of ingenuity: patient value.

Jeffrey Brewer, Co-founder, President and CEO,, Bigfoot Biomedical

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Jiren Liu, Founder, Chairman, and CEO, Neusoft Corp.

Jared Watkin, Senior Vice President, Diabetes Care, Abbott

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

040

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:35 PM

WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

 

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation

Michael Hebb, Founder, Death over Dinner

Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

040

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:35 PM

WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

 

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation

Michael Hebb, Founder, Death over Dinner

Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

FORTUNE Brainstorm Health 2022

Los Angeles, CA

Wednesday, May 11th, 2022

 

10:30 AM

BACK TO THE FUTURE: ONE ON ONE WITH DELTA’S CEO

It takes true grit to operate an airline in today’s environment - soaring fuel prices, inflation, concerns for passenger and employee safety and calls for sustainability initiatives on the heels of historic losses due to the global pandemic are all significant realities to contend with. Yet despite it all, travel demand is roaring back, recently allowing Delta to experience record breaking bookings. What the future holds for the world’s largest airline.

Ed Bastian, Chief Executive Officer, Delta Air Lines

Interviewer: Alan Murray, Chief Executive Officer, FORTUNE

 

Photograph by Stuart Isett/Fortune

009

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

4:40 PM

THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

 

James Park, Co-founder and CEO, Fitbit

Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

029

FORTUNE Brainstorm Health 2022

Los Angeles, CA

Wednesday, May 11th, 2022

 

12:00 PM

FERTILITY BENEFITS: THE NEW FRONTLINE IN EMPLOYEE RETENTION

It’s a new baby boom (of sorts): The business of fertility treatments is soaring globally, with analysts expecting the market to reach $22 billion by 2025. In 2021, nearly $200 million worth of venture capital poured into fertility startups. As treatments become more common, a growing number of companies are offering extensive fertility benefits to attract and retain high performers. With the costs of fertility treatment still untenably high for many people, what’s at stake for companies that do—or don’t—offer these benefits at scale?

TJ Farnsworth, Founder and CEO, Inception Fertility

Tammy Sun, Co-founder and CEO, Carrot Fertility

Moderator: Siobhan O’Connor, Media Executive and Journalist

 

Photograph by Stuart Isett/Fortune

005

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:10 PM

THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

 

Joe Almeida, Chairman, President and CEO, Baxter International

George Barrett, Executive Chairman, Cardinal Health

Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

016

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WHY YOU SHOULD SLEEP THROUGH THIS SESSION

The data is real. A good night of sleep can have enormous benefits for our health, well-being, and productivity. Yet, despite the science, many of us continue to forgo the shut-eye we need. Part of the reason is a profound misunderstanding of productivity and where it comes from: While today’s digital world seems to demand that we’re always connected, there’s a smarter, healthier way to get more done. We explore what individuals and companies can do to create a well-rested workplace and what impact that can have on decision making, problem solving, and the bottom line. Can we really change the culture of ALWAYS ON? Rest assured, we can.

 

Liat Ben-Zur, Senior Vice-President, Connected Digital Platforms and Propositions, Royal Philips

Roger Ekirch, Professor of History, Virginia Tech

Dr. Lauren Hale, Professor, Family, Population, and Preventive Medicine; Core Faculty, Program in Public Health, Stony Brook University School of Medicine

Cheri Mah, Research Fellow, Human Performance Center, UC San Francisco

Moderator: David Cloud, CEO, National Sleep Foundation

 

Photograph by Stuart Isett/Fortune

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

092457

Gracie Mendoza

 

Brainstormer 1- Deliverance, Chinese, Garage

 

This one was inspired by Nakamura Hikaru's manga: Saint Oniisan. It's about Jesus and Buddah having their vacation, immersing themselves in 20th Century culture and living among humans. I decided to go to this direction just because I find the notion of them living with humans of the 20th Century humorous and at the same time refreshing. Plus, it fits the words for the brainstormer.

037

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:25 PM

GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

 

Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine

Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis

Additional speakers to be announced.

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

018

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WEAPONIZING YOUR OWN BODY

The newest tool in the medical arsenal is also the oldest: the human body itself. From patient blood cells modified to become cancer killers to molecules that release the reins on our internal Green Berets, the immune system may be modern medicine’s most effective commando force. But weaponizing the body doesn’t come cheap—with new drugs now listing in the high six figures and development costs running many times that amount. From CAR-Ts to souped-up stem cells to anticancer viruses, here’s what’s driving the wildest discovery engine in science—and what still stands in our way.

Dr. Anna Barker, Co-Director, Complex Adaptive Systems, Professor, School of Life Sciences, Arizona State University

 

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Dr. Thomas Lynch, Jr., Vice President, Chief Scientific Officer, Research and Development, Bristol-Myers Squibb

Dr. Jill O’Donnell-Tormey, Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

006

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:35 PM

IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation

Dr. Margaret Hamburg, President, American Association for the Advancement of Science

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

A.I. AND THE FUTURE OF MONEY

Hosted by Refinitiv

Artificial intelligence is transforming financial services, bringing new opportunities for consumers and businesses. But A.I. is also fraught with ethical and security risks, with machines potentially making decisions on everything from credit scores to trading to lending.

Introduction: Tim Baker, Global Head of Applied Innovation, Refinitiv

Colin Beirne, Co-founder and Partner, Two Sigma Ventures

Matthew Granade, Chief Market Intelligence Officer, Point72 Asset Management; Managing Partner, Point72 Ventures

Douglas Merrill, Co-founder and CEO, ZestFinance

Rania Succar, Vice President and Business Leader, QuickBooks Payments and Capital, Intuit

Moderator: Matt Heimer, Features Editor, FORTUNE

 

Photography by Rebecca Greenfield/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

018

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WEAPONIZING YOUR OWN BODY

The newest tool in the medical arsenal is also the oldest: the human body itself. From patient blood cells modified to become cancer killers to molecules that release the reins on our internal Green Berets, the immune system may be modern medicine’s most effective commando force. But weaponizing the body doesn’t come cheap—with new drugs now listing in the high six figures and development costs running many times that amount. From CAR-Ts to souped-up stem cells to anticancer viruses, here’s what’s driving the wildest discovery engine in science—and what still stands in our way.

Dr. Anna Barker, Co-Director, Complex Adaptive Systems, Professor, School of Life Sciences, Arizona State University

 

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Dr. Thomas Lynch, Jr., Vice President, Chief Scientific Officer, Research and Development, Bristol-Myers Squibb

Dr. Jill O’Donnell-Tormey, Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

010

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:05 PM

HELPING THE LEGALLY BLIND ACTUALLY SEE

How one company, eSight, is using breakthrough wearable technology to help the legally blind discover the world around them

 

Jeffrey Fenton, Director, Outreach and Communications, eSight

 

Photograph by Stuart Isett/Fortune

040

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:35 PM

WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

 

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation

Michael Hebb, Founder, Death over Dinner

Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

CORPORATE FINANCE IN THE AGE OF CRYPTO

Virtual currency is appearing on the balance sheet of a growing number of companies, including traditional retailers and financial institutions. Yet cryptocurrency’s rollercoaster volatility means new challenges for handling everything from payments to taxes, and more. The CFO of America’s biggest virtual currency exchange and a blockchain-evangelizing e-commerce pioneer offer an inside account.

Patrick Byrne, Chief Executive Officer, Overstock.com

Alesia Haas, Chief Financial Officer, Coinbase Global Inc.

Moderator: Adam Lashinsky, FORTUNE Photography by Rebecca Greenfield/Fortune

Quella tempesta che fá esplodere la testa, che da ansia e toglie il respiro, uno vorrebbe solo un po di luce, un po di chiarezza

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

030

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:10 PM

FROM CLOUD HOSPITALS TO HUMAN CELL PRINTING: HOW CHINA IS LEADING THE WAY

Chinese entrepreneurs and leaders are racing to develop health care solutions that can better serve the country’s 1.3 billion people—and much of the inspiration for these innovations is home-grown. As China takes leaps forward in digital connectivity, big data analytics, 3D printing, and artificial intelligence, other nations—including some industrial giants—are suddenly finding themselves in the slow lane, held back by budget cuts, red tape, and entrenched systems. Some insights from one health care pioneer on what it will take to stay competitive in the global race to innovate.

 

Dr. Jiren Liu, Chairman and CEO, Neusoft Corporation

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

040

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:35 PM

WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

 

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation

Michael Hebb, Founder, Death over Dinner

Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

041

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:05 PM

TAKE TWO TERABYTES AND CALL ME IN THE MORNING: DATA’S GROWING ROLE IN THE MEDICAL TOOL BOX

At the core of precision medicine is precision: the critical need to hit, square on, a moving target in a body chock full of moving targets. To keep the aim sound, we need more than a steady hand, we need data. Smart data, and lots of it. That imperative has driven much of the innovation—and investment—in the current digital health transformation. Entrepreneurs and corporate leaders are now championing the role of big data in everything from drug development to predictive analytics in cancer diagnosis to hospital systems management—and putting billions of dollars behind these efforts. Do the numbers add up, or is the promise of big data yet another false medical miracle?

  

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

Dr. Kyu Rhee, Vice President and Chief Health Officer, IBM Corporation

Dr. Mona Siddiqui, Chief Data Officer, U.S. Dept. of Health and Human Services

 

Photograph by Stuart Isett/Fortune

1 2 ••• 59 60 62 64 65 ••• 79 80